Dupont Capital Management’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5,006
Closed -$119K 1204
2022
Q4
$119K Sell
5,006
-537
-10% -$12.5K 0.01% 903
2022
Q3
$92K Sell
5,543
-2,172
-28% -$48.9K 0.01% 1071
2022
Q2
$154K Hold
7,715
0.01% 1056
2022
Q1
$213K Sell
7,715
-683
-8% -$19.5K 0.01% 1039
2021
Q4
$346K Sell
8,398
-3,349
-29% -$148K 0.01% 930
2021
Q3
$546K Sell
11,747
-1,661
-12% -$72.5K 0.02% 817
2021
Q2
$536K Hold
13,408
0.01% 931
2021
Q1
$721K Sell
13,408
-2,750
-17% -$158K 0.02% 740
2020
Q4
$791K Sell
16,158
-1,206
-7% -$55.9K 0.02% 656
2020
Q3
$564K Sell
17,364
-1,163
-6% -$37K 0.01% 699
2020
Q2
$480K Sell
18,527
-1,655
-8% -$41.2K 0.01% 803
2020
Q1
$491K Sell
20,182
-49,296
-71% -$1.24M 0.01% 674
2019
Q4
$1.94M Hold
69,478
0.04% 362
2019
Q3
$1.67M Sell
69,478
-307
-0.4% -$8.17K 0.04% 383
2019
Q2
$1.99M Buy
69,785
+7,214
+12% +$180K 0.05% 373
2019
Q1
$1.57M Hold
62,571
0.04% 426
2018
Q4
$787K Buy
+62,571
New +$740K 0.02% 599

Other funds holding VCYT

Dupont Capital Management's VCYT Position: Q1 2023 in Review

Dupont Capital Management sold out of Veracyte (VCYT) in Q1 2023, closing a stake of 5,006 shares — an estimated $119K sold.

Dupont Capital Management first reported a position in VCYT in Q4 2018 and held it in 17 quarters. The position peaked at $1.99M in Q2 2019. 232 funds tracked by Wall St. Rank hold VCYT as of Q1 2023.

  • Dupont Capital Management reported no remaining Veracyte position as of Q1 2023 after selling out during the quarter.
  • Dupont Capital Management sold 5,006 Veracyte shares in Q1 2023, an estimated $119K.
  • Dupont Capital Management first reported a position in Veracyte in Q4 2018 and held it in 17 quarters.
  • Dupont Capital Management's Veracyte position peaked at $1.99M in Q2 2019.
  • 232 funds tracked by Wall St. Rank held Veracyte as of Q1 2023.

Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.